|
⚲
|
| Selexys Pharmaceuticals Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001442824 |
| Sale | 2008-08-11 ($3.4 M Offered, $3.4 M Sold) |
| Fund | |
| Phone | 4053198198 |
| Address | 800 Research Parkway Oklahoma City, 73104 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| William Paiva | |
| Scott Rollins | |
| Philip Jones | |
| Rodger McEver | |
| Richard Alvarez | |
| David Falconer | |
| Tom Walker |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Mittal Vikas
✚
|
0.0 | |
|
Hamlin Pamela Ann
✚
|
0.0 | |
|
Hammer Daniel W
✚
|
0.0 | |
|
Golden Mountain Financial Corp
✚
|
0.0 | |
|
Moak Donald Lee
✚
|
0.0 | |
|
Hanson Jon R
✚
|
0.0 | |
|
HarbourVest Co-Investment Opportunities Fund L.P.
✚
|
0.0 | |
|
HarbourVest IX-Venture Associates LLC
✚
|
0.0 | |
|
Molloy Lawrence
✚
|
0.0 | |
|
Hall David G
✚
|
0.0 |